Rheumatoid arthritis: open trials in Serbia

3 open trials have a site in Serbia. Registry data; only the trial team decides who can take part.

NCT07409103
A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Trial Treatment · Phase 2 · Elevara Medicines Limited
Military Medical Academy,Clinic for Rheumatology, Belgrade · Institute of Rheumatology, Belgrade · Special Hospital For Rheumatic Diseases Novi Sad, Novi Sad
Registry updated 2026-10-23
NCT06972446
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Trial Treatment · Phase 2 · AbbVie
Institute Of Rheumatology /ID# 280054, Belgrade · Institute Of Rheumatology /ID# 280055, Belgrade · Specijalna Bolnica za Reumatske bolesti Novi Sad /ID# 280057, Novi Sad · Specijalna Bolnica za Reumatske bolesti Novi Sad /ID# 280058, Novi Sad
Registry updated 2026-10-08
NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Trial Treatment · Phase 2 · Artiva Biotherapeutics, Inc.
Artiva Investigational Site Belgrade, Belgrade
Registry updated 2026-07-31

This page is not medical advice. Talk to your doctor before contacting a trial.

A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)